The Expanding Role of New Medications in the Treatment of Type 2 Diabetes Mellitus
We examined the prevalence of use and cost impact of DPP-4 inhibitors and GLP-1 receptor agonists in people with diabetes.
Read More
Conventional and Biologic Rheumatoid Arthritis Therapies: Utilization and Cost Trends
Based on American College of Rheumatology recommendations and novel emerging treatment options, the trend of increasing biologic use for rheumatoid arthritis is expected to continue.
Read More